Sequential Response to FGFR3 Inhibition With Subsequent Exceptional Response to Atezolizumab in a Patient With FGFR3-TACC3 Fusion-Positive Metastatic Urothelial Carcinoma.
Ontology highlight
SUBMITTER: Nassar AH
PROVIDER: S-EPMC7885951 | biostudies-literature | 2018
REPOSITORIES: biostudies-literature
ACCESS DATA